Abigail D. Winder

Abigail D. Winder

Oncology
2160 S First Ave
Bld 103 Rm 1020
Maywood, IL 60153

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Outcomes of an Alpha-DC-1 Dendritic Cell-Based Vaccine Clinical Trial in Patients with Low-Tumor-Burden High-Risk Ovarian Carcinoma.

Outcomes of an Alpha-DC-1 Dendritic Cell-Based Vaccine Clinical Trial in Patients with Low-Tumor-Burden High-Risk Ovarian Carcinoma.

Journal: Cancers
Published: March 04, 2026

Gynecologic Oncology Patients have Urobiomes that are Similar to Women Without Gynecologic Cancer.

Gynecologic Oncology Patients have Urobiomes that are Similar to Women Without Gynecologic Cancer.

Journal: International urogynecology journal
Published: March 18, 2025

Evaluating outcomes and toxicities for a newly implemented MRI-based brachytherapy program for cervical cancer.

Evaluating outcomes and toxicities for a newly implemented MRI-based brachytherapy program for cervical cancer.

Journal: Gynecologic oncology
Published: December 19, 2023

Uterine perforation during brachytherapy for cervical cancer: Complications, outcomes, and best practices for forward treatment planning and management.

Uterine perforation during brachytherapy for cervical cancer: Complications, outcomes, and best practices for forward treatment planning and management.

Journal: Brachytherapy
Published: June 24, 2020

Salvage treatment in recurrent endometrial cancer of the pelvis and peritoneal cavity.

Salvage treatment in recurrent endometrial cancer of the pelvis and peritoneal cavity.

Journal: Gynecologic oncology reports
Published: February 15, 2019

Surgery and Platinum/Etoposide-Based Chemotherapy for the Treatment of Epithelioid Trophoblastic Tumor.

Surgery and Platinum/Etoposide-Based Chemotherapy for the Treatment of Epithelioid Trophoblastic Tumor.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 15, 2018

Does adjuvant concurrent or sequential chemotherapy increase the radiation-related toxicity of vaginal brachytherapy for endometrial cancer patients?

Does adjuvant concurrent or sequential chemotherapy increase the radiation-related toxicity of vaginal brachytherapy for endometrial cancer patients?

Journal: Brachytherapy
Published: April 30, 2018

Comparison of dosimetric and clinical outcomes between short- and long-channel cylinder applicators for vaginal brachytherapy in intermediate- and high-risk endometrial cancer.

Comparison of dosimetric and clinical outcomes between short- and long-channel cylinder applicators for vaginal brachytherapy in intermediate- and high-risk endometrial cancer.

Journal: Brachytherapy
Published: December 13, 2017

Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program.

Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program.

Journal: Brachytherapy
Published: June 22, 2017

The "hook effect" causing a negative pregnancy test in a patient with an advanced molar pregnancy.

The "hook effect" causing a negative pregnancy test in a patient with an advanced molar pregnancy.

Journal: Gynecologic oncology reports
Published: March 29, 2017

The allosteric AKT inhibitor, MK2206, decreases tumor growth and invasion in patient derived xenografts of endometrial cancer.

The allosteric AKT inhibitor, MK2206, decreases tumor growth and invasion in patient derived xenografts of endometrial cancer.

Journal: Cancer biology & therapy
Published: January 24, 2017

Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.

Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.

Journal: Cancer
Published: September 16, 2016
Showing 1-12 of 16

Last Updated: 09/26/2026